TY - JOUR
T1 - Prognostic factor of the two-year mortality after revascularization in patients with critical limb ischemia
AU - Morisaki, Koichi
AU - Matsumoto, Takuya
AU - Matsubara, Yutaka
AU - Inoue, Kentaro
AU - Aoyagi, Yukihiko
AU - Matsuda, Daisuke
AU - Tanaka, Shinichi
AU - Okadome, Jun
AU - Maehara, Yoshihiko
N1 - Publisher Copyright:
© 2016, © The Author(s) 2016.
PY - 2017/4/1
Y1 - 2017/4/1
N2 - Purposes: The aim of this study was to evaluate the risk factors for the two-year survival after revascularization of critical limb ischemia. Methods: Between 2008 and 2012, 142 patients underwent revascularization. A retrospective analysis was performed to measure the risk factor. Results: A total 85 patients underwent surgical revascularization, 31 patients underwent endovascular therapy while 26 patients underwent hybrid therapy. By multivariate analysis, the following variables were considered to be risk factors: ejection fraction <50 % (HR, 3.14; 95% CI, 1.22–7.95; P = 0.02), serum albumin level <2.5 g/dL (HR, 3.45; 95% CI, 1.01–11.7; P = 0.04) and nonambulatory status (HR, 4.11; 95% CI, 1.79–9.70; P < 0.01). The two-year survival rate of the patients with no risk factors was 85.5%, while the patients with at least one risk factor had an unfavorable prognosis (one; 56.7%, two; 45.4%). Conclusions: The nonambulatory status, serum albumin level <2.5 g/dL and ejection fraction <50% were the risk factors for the two-year mortality after revascularization in critical limb ischemia patients. These risk factors may be useful for the treatment strategy of critical limb ischemia patients.
AB - Purposes: The aim of this study was to evaluate the risk factors for the two-year survival after revascularization of critical limb ischemia. Methods: Between 2008 and 2012, 142 patients underwent revascularization. A retrospective analysis was performed to measure the risk factor. Results: A total 85 patients underwent surgical revascularization, 31 patients underwent endovascular therapy while 26 patients underwent hybrid therapy. By multivariate analysis, the following variables were considered to be risk factors: ejection fraction <50 % (HR, 3.14; 95% CI, 1.22–7.95; P = 0.02), serum albumin level <2.5 g/dL (HR, 3.45; 95% CI, 1.01–11.7; P = 0.04) and nonambulatory status (HR, 4.11; 95% CI, 1.79–9.70; P < 0.01). The two-year survival rate of the patients with no risk factors was 85.5%, while the patients with at least one risk factor had an unfavorable prognosis (one; 56.7%, two; 45.4%). Conclusions: The nonambulatory status, serum albumin level <2.5 g/dL and ejection fraction <50% were the risk factors for the two-year mortality after revascularization in critical limb ischemia patients. These risk factors may be useful for the treatment strategy of critical limb ischemia patients.
UR - http://www.scopus.com/inward/record.url?scp=85016133090&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85016133090&partnerID=8YFLogxK
U2 - 10.1177/1708538116651216
DO - 10.1177/1708538116651216
M3 - Article
C2 - 27206469
AN - SCOPUS:85016133090
SN - 1708-5381
VL - 25
SP - 123
EP - 129
JO - Vascular
JF - Vascular
IS - 2
ER -